Cita APA (7a ed.)
Gardin, A., Shakeri-Nejad, K., Feller, A., Huth, F., Neelakantham, S., & Dumitras, S. (2019). Siponimod pharmacokinetics, safety, and tolerability in combination with the potent CYP3A4 inhibitor itraconazole in healthy subjects with different CYP2C9 genotypes. European Journal of Clinical Pharmacology, 75(11), 1565-1575.
Cita Chicago Style (17a ed.)
Gardin, Anne, Kasra Shakeri-Nejad, Andrea Feller, Felix Huth, Srikanth Neelakantham, y Swati Dumitras. "Siponimod Pharmacokinetics, Safety, and Tolerability in Combination with the Potent CYP3A4 Inhibitor Itraconazole in Healthy Subjects with Different CYP2C9 Genotypes." European Journal of Clinical Pharmacology 75, no. 11 (2019): 1565-1575.
Cita MLA (9a ed.)
Gardin, Anne, et al. "Siponimod Pharmacokinetics, Safety, and Tolerability in Combination with the Potent CYP3A4 Inhibitor Itraconazole in Healthy Subjects with Different CYP2C9 Genotypes." European Journal of Clinical Pharmacology, vol. 75, no. 11, 2019, pp. 1565-1575.
Precaución: Estas citas no son 100% exactas.